Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 3
This trial is looking at a drug called polatuzumab vedotin in combination with a treatment called RICE for B cell lymphoma.
It is open to people with diffuse large B cell lymphoma:
when the has stopped working
that has come back after treatment
Recruitment start: 18 August 2022
Recruitment end: 31 December 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Davies
Cancer Research UK
F. Hoffmann - La Roche, Limited
Southampton Clinical Trials Unit
GWT-TUD GmbH
AGMT
Geltamo
This is Cancer Research UK trial number CRUKE/21/006.
Last reviewed: 2 January 2025
CRUK internal database number: 18445
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
